Tudor Investment Corp
TARO

Tudor Investment Corp’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Tudor Investment Corp’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,431
Closed -$216K – 3064
2022
Q4 		$216K Buy
+7,431
New +$220K ﹤0.01% 2106
2021
Q2 		– Sell
-2,885
Closed -$213K – 2028
2021
Q1 		$213K Buy
+2,885
New +$219K ﹤0.01% 1410
2018
Q4 		– Sell
-3,300
Closed -$324K – 1272
2018
Q3 		$324K Buy
+3,300
New +$357K 0.01% 829
2018
Q1 		– Sell
-4,629
Closed -$485K – 1304
2017
Q4 		$485K Sell
4,629
-912
-16% -$100K 0.01% 623
2017
Q3 		$624K Sell
5,541
-7,874
-59% -$857K 0.02% 569
2017
Q2 		$1.5M Sell
13,415
-1,374
-9% -$155K 0.05% 236
2017
Q1 		$1.73M Buy
14,789
+629
+4% +$69.6K 0.05% 217
2016
Q4 		$1.49M Buy
14,160
+6,524
+85% +$683K 0.04% 234
2016
Q3 		$844K Buy
7,636
+4,973
+187% +$659K 0.02% 468
2016
Q2 		$388K Buy
+2,663
New +$378K 0.01% 1011

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Tudor Investment Corp's TARO Position: Q1 2023 in Review

Tudor Investment Corp sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2023, closing a stake of 7,431 shares — an estimated $216K sold.

Tudor Investment Corp first reported a position in TARO in Q2 2016 and held it in 10 quarters. The position peaked at $1.73M in Q1 2017. 62 funds tracked by Wall St. Rank hold TARO as of Q1 2023.

  • Tudor Investment Corp reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 7,431 Taro Pharmaceutical Industries Ltd. shares in Q1 2023, an estimated $216K.
  • Tudor Investment Corp first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 10 quarters.
  • Tudor Investment Corp's Taro Pharmaceutical Industries Ltd. position peaked at $1.73M in Q1 2017.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.